{
  "id": "Ex001",
  "type": "Example",
  "informationId": {
    "id": "CG-EX:CritAssess275",
    "type": "CriterionAssessment",
    "criterion": {
      "id": "Crit303",
      "type": "Criterion",
      "description": "null variant (nonsense, frameshift, canonical Â±1 or 2 splice sites, initiation codon, single or multiexon deletion) in a gene where LOF is a known mechanism of disease",
      "comments": "The two main concerns for applying this rule is:\na. Is LOF an established disease mechanism?\nb. Is LOF actually occurring?",
      "defaultStrength": {
        "id": "SEPIO:0000220",
        "label": "Pathogenic Very Strong"
      },
      "label": "PVS1"
    },
    "variant": {
      "id": "CAR:CA090943",
      "type": "CanonicalAllele",
      "preferredCtxAllele": {
        "id": "CG-EX:CtxAll001",
        "type": "ContextualAllele",
        "relatedCanonicalAllele": "CAR:CA090943",
        "alleleName": "NM_031844.2(HNRNPU):c.2304_2305del (p.Gly769Glufs*83)"
      }
    },
    "outcome": {
      "id": "SEPIO:0000224",
      "label": "Not Met"
    },
    "evidenceLine": [
      {
        "id": "CG-EX:EvLn001",
        "type": "EvidenceLine",
        "evidenceItem": [
          {
            "id": "CG-EX:MolCon001",
            "type": "AlleleMolecularConsequence",
            "contextualAllele": {
              "id": "CG-EX:CtxAll001",
              "type": "ContextualAllele",
              "relatedCanonicalAllele": "CAR:CA090943",
              "alleleName": "NM_031844.2(HNRNPU):c.2304_2305del (p.Gly769Glufs*83)"
            },
            "consequence": {
              "id": "SO:0001589",
              "label": "frameshift variant"
            },
            "description": "Protein ends at p.826 and this frameshift would create stop at p.852 (769+83) thus NMD would not occur. Instead an elongated protein"
          },
          {
            "id": "CG-EX:Null396",
            "type": "NullAllele",
            "contextualAllele": {
              "id": "CG-EX:CtxAll001",
              "type": "ContextualAllele",
              "relatedCanonicalAllele": "CAR:CA090943",
              "alleleName": "NM_031844.2(HNRNPU):c.2304_2305del (p.Gly769Glufs*83)"
            },
            "annotation": {
              "id": "SO:0002055",
              "label": "null mutation"
            },
            "qualifier": "NOT"
          },
          {
            "id": "CG-EX:CondMech002",
            "type": "ConditionMechanism",
            "mechanism": {
              "id": "SO:0002054",
              "label": "loss of function variant"
            },
            "mechanismConfidence": {
              "id": "SEPIO:0000269",
              "label": "established"
            },
            "gene": {
              "id": "HGNC:5048",
              "label": "HNRNPU"
            },
            "description": "HNRNPU is not associated with any conditions, and therefore LOF is not an established mechanism of any condition for this gene."
          }
        ]
      }
    ],
    "contribution": [
      {
        "type": "Contribution",
        "agent": {
          "id": "CG-EX:Agent001",
          "type": "Agent",
          "label": "Harry Stevenson"
        },
        "contributionDate": "6/1/16 10:10 AM",
        "contributionRole": {
          "id": "SEPIO:0000154",
          "label": "assessor role"
        }
      }
    ],
    "description": "Variant is not LOF and LOF is not a known mechanism of disease associated with this gene for any condition."
  },
  "index": 1,
  "author": "Steven Harrison",
  "description": "Variant: NM_031844.2(HNRNPU):c.2304_2305del (p.Gly769Glufs*83)\nVariant is frameshift which would be LOF however PVS1 is not applicable because:\na. LOF is not an established disease mechanism for HNRNPU\nb. Protein ends at p.826 and this frameshift would create stop at p.852 (769+83) thus NMD would not occur. Instead an elongated protein",
  "@context": "http://datamodel.clinicalgenome.org/interpretation/json/context"
}
